OPPENHEIMER ASSET MANAGEMENT INC. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$329,911
-22.2%
17,165
+2.9%
0.01%
-16.7%
Q2 2023$424,056
-21.1%
16,682
+12.2%
0.01%
-25.0%
Q1 2023$537,587
-7.2%
14,871
+1.6%
0.01%
-11.1%
Q4 2022$579,506
+36.0%
14,634
+60.0%
0.01%
+12.5%
Q3 2022$426,000
-30.8%
9,149
-34.9%
0.01%
-20.0%
Q2 2022$616,000
-30.5%
14,060
+14.8%
0.01%
-23.1%
Q1 2022$886,000
-1.7%
12,246
+10.1%
0.01%
+8.3%
Q4 2021$901,000
-49.3%
11,118
-27.2%
0.01%
-52.0%
Q3 2021$1,778,000
-32.2%
15,272
-3.5%
0.02%
-32.4%
Q2 2021$2,624,000
+29.7%
15,829
+9.1%
0.04%
+19.4%
Q1 2021$2,023,000
-16.3%
14,506
+3.9%
0.03%
-22.5%
Q4 2020$2,417,000
+20.4%
13,960
-3.2%
0.04%
+2.6%
Q3 2020$2,008,000
+30.4%
14,416
+11.9%
0.04%
+21.9%
Q2 2020$1,540,000
+65.9%
12,888
+38.9%
0.03%
+39.1%
Q1 2020$928,000
-23.1%
9,277
-9.6%
0.02%
-8.0%
Q4 2019$1,206,000
+19.8%
10,264
-12.4%
0.02%
+13.6%
Q3 2019$1,007,000
+56.1%
11,718
+17.8%
0.02%
+57.1%
Q2 2019$645,000
+15.6%
9,949
+11.4%
0.01%
+7.7%
Q1 2019$558,000
+393.8%
8,930
+206.5%
0.01%
+333.3%
Q4 2018$113,000
+61.4%
2,914
+281.4%
0.00%
+50.0%
Q3 2017$70,000
+20.7%
764
-1.5%
0.00%0.0%
Q2 2017$58,000
+176.2%
776
+248.0%
0.00%
+100.0%
Q1 2017$21,0002230.00%
Other shareholders
NEVRO CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders